Xilio Therapeutics XLO
NASDAQ XLO
$9.23 +0.00 (+0.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Xilio Therapeutics (XLO) EBT Margin Growth (1y) (2025 - 2026)

Xilio Therapeutics (XLO) EBT Margin Growth (1y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -153.00
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -571.00
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 546.00
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 4,709.00
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1,076.00
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1,911.00
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -2,507.00
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 29,565.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -392.00
10 Xilio Therapeutics 178.33 Mn 42.29 Mn - 15,903.00

Historic Data

Download Data
DateValue
Jun 30, 2026 15,882.00
Mar 31, 2026 36,302.00
Dec 31, 2025 72,022.00
Sep 30, 2025 64,622.00
Jun 30, 2025 45,308.00